Title: Effects of moxifloxacin combined with regimen in the treatment of patients with drug-resistant pulmonary tuberculosis
Abstract: Objective To investigate the clinic effect and safety of moxifloxacin combined with regimen in the treatment of patients with drug-resistant pulmonary tuberculosis.Methods A total of 74 drug-resistant pulmonary tuberculosis patients were collected in this study.The 74 cases were randomly and evenly divided into two groups.The sputum negative conversion rates,clinic and side effects of drugs were compared between the two groups.Results 12 months after the treatment,the sputum negative conversion rates in the treatment group was higher than that in the control group(P0.05).At the end of treatment the sputum negative conversion rates in the treatment group was 93.3% and 62.5% in the controls(P0.05).The effective rate in the treatment group was 83.3%,and in the control group it was 56.2%.There was significant different between the two groups(P0.05).The rates of side effects were 31.2% and 33.4% in the control group and the treatment group respectively with no significant different(P0.05).Conclusion Moxifloxacin combined with regimen can effectively treat patients with drug-resistant pulmonary tuberculosis,which is worth to be promoted in clinical application.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot